Plain-English translation of NCT06959316 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →This study is gathering real-world information from pregnant people with type 1 diabetes across the United States. Researchers want to understand how hybrid closed-loop insulin delivery systems (automated insulin pumps that adjust on their own) compare to other insulin delivery methods for managing blood sugar during pregnancy. The study will look at whether these systems help achieve better blood sugar control and safer pregnancy outcomes.
Type 1 diabetes during pregnancy carries serious risks for both mother and baby if blood sugar isn't well controlled. Hybrid closed-loop systems may help with blood sugar management, but they're not yet approved for pregnancy use and may not be set to the stricter targets that pregnancy requires. This study will gather evidence about whether these systems work well during pregnancy and what real-world adjustments people are making to use them safely.
You likely qualify if…
You likely don't qualify if…
This is a remote study, so you would participate from home. You'll be asked to complete surveys about your diabetes management and pregnancy, and to share data from your continuous glucose monitor and insulin pump (if you use one). The study follows you throughout your pregnancy and continues after delivery to track both your health and your baby's health. There are no in-person visits required.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States